Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

August 14, 2023

Primary Completion Date

July 30, 2024

Study Completion Date

January 31, 2025

Conditions
Vitiligo
Interventions
DEVICE

RECELL® Autologous Cell Harvesting Device

The RECELL Device is for use at the patient's point-of-care for the safe and rapid preparation of Spray-On SkinTM Cells from a small sample of a patient's own skin.

Trial Locations (17)

10012

The Dermatology Specialist, New York

10028

Mount Sinai, New York

20815

Dermatologic Surgery Center of Washington, Chevy Chase

21030

Maryland Laser, Skin & Vein Institute, Hunt Valley

28207

Dermatology, Laser and Vein Specialists of the Carolinas, Charlotte

33021

Skin Care Research, LLC, Hollywood

33437

Siperstein Dermatology Group, Boynton Beach

48088

Grekin Skin Institute, Warren

48187

Hamzavi Dermatology, Canton

48202

Henry Ford Health, Detroit

80109

Clarity Dermatology, Castle Rock

85225

Affiliated Dermatology, Scottsdale

91320

California Dermatology Institute, Thousand Oaks

92121

West Dermatology Research Center, San Diego

92697

University of California, Irvine, Irvine

94086

Sutter Health, Sunnyvale

01605

University Of Massachusetts, Worcester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Avita Medical

INDUSTRY